Medical Condition News

RSS

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

2 Mar 2010

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.

2 Mar 2010

French investigation explores the outcome of physical functioning of coronary angioplasty

A French investigation published in the current issue of Psychotherapy and Psychosomatics has explored the outcome in terms of physical functioning of coronary angioplasty.

2 Mar 2010

Problems controlling common diseases could be hindering efforts to meet key child health goals

Problems controlling common diseases like HIV, heart disease and diabetes in poor countries could be hindering efforts to meet the world's key child health and tuberculosis goals, a new study published in PLoS Medicine has warned.

2 Mar 2010

California's dirty air costs more than $193M in hospital-based medical care, finds RAND study

California's dirty air caused more than $193 million in hospital-based medical care from 2005 to 2007 as people sought help for problems such as asthma and pneumonia that are triggered by elevated pollution levels, according to a new RAND Corporation study.

2 Mar 2010

Fluorescence method predicts the efficacy of PDT for Port Wine Stains: Study

It is known that fluctuations in the treatment outcome of photodynamic therapy (PDT) between patients are related to the concentration of photosensitizer in target tissue. The purpose of a study, by Wang et al, published in the February 2010 issue of Experimental Biology and Medicine was to establish a fluorescence method not only providing a semi-quantitative measurement of photosensitizer concentration but also predicting the efficacy of PDT for Port Wine Stains (PWS).

2 Mar 2010

Sea squirts help in fight against Alzheimer's disease

Alzheimer's disease affects an estimated 27 million people worldwide. It is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the characteristic changes in the brains of Alzheimer's patients is the accumulation of plaques and tangles; currently, the best hope for curing or at least slowing the disease lies in developing drugs that target this buildup.

2 Mar 2010

Future work may uncover links between insulin use and cancer risk, say researchers

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

2 Mar 2010

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional pharmacokinetic data presented at the meeting confirms that C1-INH concentrate has a longer half-life than other treatment options for HAE, which protects patients from rebound attacks.

2 Mar 2010

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer's disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment. In a groundbreaking study published in the February 2010 issue of the Journal of Alzheimer's Disease investigators successfully used artificial neural networks (ANNs) to help understand the causal relation between multiple factors and the occurrence of neurodegenerative disorders.

2 Mar 2010

Consumption of garlic reduces level of potential carcinogenic processes

Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.

2 Mar 2010

Scientists show omega-3 fatty acid and its derivatives kill neuroblastoma cancer cells

The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.

2 Mar 2010

Prevention of 21% cuts in Medicare payments to physicians: Congress fails to approve, AADA disappointed

The American Academy of Dermatology Association (AADA) is disappointed that the United States Congress has failed to approve legislation preventing the implementation of a 21 percent cut in payments for physicians who treat Medicare patients.

2 Mar 2010

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented today at the 2010 American Academy of Allergy, Asthma & Immunology Annual Meeting.

2 Mar 2010

GenWay Biotech's simple blood sample cancer assessment test

San Diego-based GenWay Biotech, Inc. today announced the availability of the You Test You- Cancer Assessment that allows patients to test for various types of cancer without having to visit their doctor's office, through a simple blood sample. With a 10-day turnaround time and a cost of $149, You Test You- is a convenient and low cost way to periodically test for indication of cancer.

2 Mar 2010

Archimedes Pharma raises GBP65 million in new funding

Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.

2 Mar 2010

Praxis to provide patient recruitment services for international type 2 diabetes study

Praxis, a company specializing in centralized patient recruitment for clinical research studies, will provide patient recruitment services to a top 20 pharmaceutical company for an international study on type 2 diabetes. The study explores an investigational drug’s effectiveness for maintaining glycemic control for individuals newly diagnosed with type 2 diabetes.

2 Mar 2010

Ban Asbestos Now campaign launched to educate public on the dangers of asbestos inhalation

"Ban Asbestos Now," a national campaign to build awareness of the continued use of asbestos in the United States, launched today to educate the public on the dangers of asbestos inhalation and urge Americans to pressure U.S. lawmakers to finally ban this toxic and often deadly substance. It is considered "the largest manmade public health crisis in history" according to the Asbestos Disease Awareness Organization.

2 Mar 2010

Focal dystonia precipitated by odor exposure: First case reported

Alan Hirsch, MD, founder and neurologic director of the Smell & Taste Treatment and Research Foundation, presented his research on Odor-Induced Pseudodystonia at the 3rd International Congress on Gait and Mental Function in Washington, D.C. on February 27.

2 Mar 2010

Study: EIB may affect lives and health of public if not addressed properly

For the vast majority of the general public, respiratory symptoms such as shortness of breath, wheezing or coughing are a common part of the exercise experience. However, together with chest tightness, noisy breathing and trouble taking a deep breath, these six symptoms make up the phenomenon known as exercise-induced bronchospasm (EIB), which has physical, emotional and psychological consequences if not addressed properly.

2 Mar 2010

Medical Condition News

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

French investigation explores the outcome of physical functioning of coronary angioplasty

Problems controlling common diseases could be hindering efforts to meet key child health goals

California's dirty air costs more than $193M in hospital-based medical care, finds RAND study

Fluorescence method predicts the efficacy of PDT for Port Wine Stains: Study

Sea squirts help in fight against Alzheimer's disease

Future work may uncover links between insulin use and cancer risk, say researchers

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

Consumption of garlic reduces level of potential carcinogenic processes

Scientists show omega-3 fatty acid and its derivatives kill neuroblastoma cancer cells

Prevention of 21% cuts in Medicare payments to physicians: Congress fails to approve, AADA disappointed

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

GenWay Biotech's simple blood sample cancer assessment test

Archimedes Pharma raises GBP65 million in new funding

Praxis to provide patient recruitment services for international type 2 diabetes study

Ban Asbestos Now campaign launched to educate public on the dangers of asbestos inhalation

Focal dystonia precipitated by odor exposure: First case reported

Study: EIB may affect lives and health of public if not addressed properly

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News